Search research articles
Contact Us
Filters
Showing results (21-30 of 28) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 28 results.
HIV Medicine
|
December 4, 2018
Does region of origin influence the timing and outcome of first-line antiretroviral therapy in France?
C Gatey, A Brun, G Hamet, et al.
International Journal of STD & AIDS
|
March 27, 2014
Risk factors for adherence failure in HIV-infected sub-Saharan migrants living in France and travelling back to their native country
S Abgrall, L Fugon, N Lélé, et al.
The Journal of Antimicrobial Chemotherapy
|
June 4, 2011
Comparative effectiveness of continuing a virologically effective first-line boosted protease inhibitor combination or of switching to a three-drug regimen containing either efavirenz, nevirapine or abacavir
T Bommenel, O Launay, J L Meynard, et al.
HIV Medicine
|
November 5, 2024
Viral rebound on antiretroviral therapy in France according to region of origin, sex, and HIV acquisition group. Results from the French Hospital Database on HIV (ANRS CO4-FHDH)
S Abgrall, H Selinger-Leneman, E Lanoy, et al.
Tuberculosis (Edinburgh, Scotland)
|
May 23, 2008
Anti-PGL-Tb1 responses as an indicator of the immune restoration syndrome in HIV-TB patients
N Simonney, G Dewulf, J-L Herrmann, et al.
Infectious Diseases Now
|
February 16, 2022
Factors associated with hospital admission and adverse outcome for COVID-19: Role of social factors and medical care
A-L Beaumont, D Vignes, R Sterpu, et al.
HIV Medicine
|
August 9, 2011
The effect of injecting drug use history on disease progression and death among HIV-positive individuals initiating combination antiretroviral therapy: collaborative cohort analysis
M Murray, R S Hogg, V D Lima, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 8, 2013
The incidence of AIDS-defining illnesses at a current CD4 count ≥ 200 cells/μL in the post-combination antiretroviral therapy era
A Mocroft, H J Furrer, J M Miro, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 28) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 28 results.
HIV Medicine
|
December 4, 2018
Does region of origin influence the timing and outcome of first-line antiretroviral therapy in France?
C Gatey, A Brun, G Hamet, et al.
International Journal of STD & AIDS
|
March 27, 2014
Risk factors for adherence failure in HIV-infected sub-Saharan migrants living in France and travelling back to their native country
S Abgrall, L Fugon, N Lélé, et al.
The Journal of Antimicrobial Chemotherapy
|
June 4, 2011
Comparative effectiveness of continuing a virologically effective first-line boosted protease inhibitor combination or of switching to a three-drug regimen containing either efavirenz, nevirapine or abacavir
T Bommenel, O Launay, J L Meynard, et al.
HIV Medicine
|
November 5, 2024
Viral rebound on antiretroviral therapy in France according to region of origin, sex, and HIV acquisition group. Results from the French Hospital Database on HIV (ANRS CO4-FHDH)
S Abgrall, H Selinger-Leneman, E Lanoy, et al.
Tuberculosis (Edinburgh, Scotland)
|
May 23, 2008
Anti-PGL-Tb1 responses as an indicator of the immune restoration syndrome in HIV-TB patients
N Simonney, G Dewulf, J-L Herrmann, et al.
Infectious Diseases Now
|
February 16, 2022
Factors associated with hospital admission and adverse outcome for COVID-19: Role of social factors and medical care
A-L Beaumont, D Vignes, R Sterpu, et al.
HIV Medicine
|
August 9, 2011
The effect of injecting drug use history on disease progression and death among HIV-positive individuals initiating combination antiretroviral therapy: collaborative cohort analysis
M Murray, R S Hogg, V D Lima, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 8, 2013
The incidence of AIDS-defining illnesses at a current CD4 count ≥ 200 cells/μL in the post-combination antiretroviral therapy era
A Mocroft, H J Furrer, J M Miro, et al.
Page
of 3